Interferon-alpha combined with ketoprofen as treatment of naïve patients with chronic hepatitis C: a randomized controlled trial. (Q43840047)

From Wikidata

Jump to navigation Jump to search

scientific article published in July 2003

edit

Language	Label	Description	Also known as
English	Interferon-alpha combined with ketoprofen as treatment of naïve patients with chronic hepatitis C: a randomized controlled trial.	scientific article published in July 2003

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12823598

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 November 2019

title

Interferon-alpha combined with ketoprofen as treatment of naïve patients with chronic hepatitis C: a randomized controlled trial (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12823598

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 November 2019

main subject

(RS)-ketoprofen

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

author

Elisabetta Loggi

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12823598

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 November 2019

Pietro Andreone

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12823598

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 November 2019

Carmela Cursaro

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12823598

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 November 2019

author name string

A Gramenzi

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12823598

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 November 2019

M Biselli

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12823598

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 November 2019

S Lorenzini

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12823598

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 November 2019

F Felline

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12823598

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 November 2019

S Fiorino

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12823598

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 November 2019

L Di Giammarino

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12823598

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 November 2019

F Porzio

series ordinal

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12823598

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 November 2019

S Galli

series ordinal

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12823598

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 November 2019

M Bernardi

series ordinal

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12823598

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 November 2019

publication date

1 July 2003

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12823598

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 November 2019

published in

Journal of Viral Hepatitis

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12823598

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 November 2019

volume

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12823598

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 November 2019

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12823598

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 November 2019

page(s)

306-309

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12823598

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 November 2019

cites work

The treatment of chronic viral hepatitis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00449.X

retrieved

21 January 2018

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00449.X

retrieved

21 January 2018

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00449.X

retrieved

21 January 2018

Peginterferon alfa-2a in patients with chronic hepatitis C.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00449.X

retrieved

21 January 2018

Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00449.X

retrieved

21 January 2018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00449.X

retrieved

21 January 2018

Interferon-alpha 2b combined with daily ketoprofen administration improves virological response in chronic hepatitis C: a prospective and randomised trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00449.X

retrieved

21 January 2018

Interferon alfa-2b alone or in combination with ketoprofen as treatment for interferon-naive chronic hepatitis C patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00449.X

retrieved

21 January 2018

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00449.X

retrieved

21 January 2018

Identifiers

DOI

10.1046/J.1365-2893.2003.00449.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12823598

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 November 2019

PubMed publication ID

12823598

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12823598

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12823598%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 November 2019

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43840047&oldid=2103787679"